CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).